Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TGTX |
---|---|---|
09:32 ET | 46969 | 17.295 |
09:34 ET | 2562 | 17.305 |
09:36 ET | 4290 | 17.2999 |
09:38 ET | 28277 | 17.25 |
09:39 ET | 4083 | 17.25 |
09:41 ET | 15014 | 17.26 |
09:43 ET | 11611 | 17.285 |
09:45 ET | 3118 | 17.28 |
09:48 ET | 5536 | 17.34 |
09:50 ET | 10635 | 17.29 |
09:52 ET | 2933 | 17.34 |
09:54 ET | 2958 | 17.36 |
09:56 ET | 17214 | 17.395 |
09:57 ET | 20410 | 17.42 |
09:59 ET | 3400 | 17.365 |
10:01 ET | 9100 | 17.345 |
10:03 ET | 10532 | 17.4 |
10:06 ET | 3976 | 17.35 |
10:08 ET | 2054 | 17.32 |
10:10 ET | 14213 | 17.285 |
10:12 ET | 57775 | 17.18 |
10:14 ET | 8669 | 17.19 |
10:15 ET | 12625 | 17.2193 |
10:17 ET | 5205 | 17.17 |
10:19 ET | 11780 | 17.17 |
10:21 ET | 5687 | 17.185 |
10:24 ET | 539 | 17.22 |
10:26 ET | 14738 | 17.2 |
10:28 ET | 15477 | 17.185 |
10:30 ET | 21887 | 17.17 |
10:32 ET | 7067 | 17.155 |
10:33 ET | 8206 | 17.12 |
10:35 ET | 16564 | 17.14 |
10:37 ET | 10418 | 17.08 |
10:39 ET | 37248 | 17.06 |
10:42 ET | 2513 | 17.1 |
10:44 ET | 2800 | 17.1299 |
10:46 ET | 19446 | 17.1 |
10:48 ET | 2500 | 17.11 |
10:50 ET | 29512 | 17.085 |
10:51 ET | 511 | 17.09 |
10:53 ET | 975 | 17.0799 |
10:55 ET | 4038 | 17.065 |
10:57 ET | 13485 | 17.02 |
11:00 ET | 25317 | 16.9827 |
11:02 ET | 15258 | 17.0191 |
11:04 ET | 8891 | 17.01 |
11:06 ET | 4985 | 17.04 |
11:08 ET | 6661 | 17.0248 |
11:09 ET | 3850 | 17.0591 |
11:11 ET | 12230 | 17.0501 |
11:13 ET | 2200 | 17.06 |
11:15 ET | 200 | 17.06 |
11:18 ET | 1885 | 17.0758 |
11:20 ET | 4630 | 17.07 |
11:22 ET | 3041 | 17.055 |
11:24 ET | 450 | 17.06 |
11:26 ET | 4423 | 17.05 |
11:27 ET | 300 | 17.075 |
11:29 ET | 3490 | 17.05 |
11:31 ET | 3903 | 17.02 |
11:33 ET | 3000 | 17.0101 |
11:36 ET | 10493 | 16.99 |
11:38 ET | 326 | 16.98 |
11:40 ET | 4168 | 16.99 |
11:42 ET | 1930 | 16.96 |
11:44 ET | 6734 | 16.96 |
11:45 ET | 3400 | 16.96 |
11:47 ET | 4058 | 17 |
11:49 ET | 6861 | 16.98 |
11:51 ET | 5523 | 17.01 |
11:54 ET | 13578 | 16.95 |
11:56 ET | 2000 | 16.9786 |
11:58 ET | 2263 | 16.98 |
12:00 ET | 2800 | 16.99 |
12:02 ET | 3149 | 16.9892 |
12:03 ET | 4515 | 16.98 |
12:05 ET | 3726 | 16.98 |
12:07 ET | 2430 | 16.99 |
12:09 ET | 2562 | 16.98 |
12:12 ET | 1713 | 16.99 |
12:14 ET | 3995 | 16.97 |
12:16 ET | 28094 | 16.9733 |
12:18 ET | 1230 | 16.97 |
12:20 ET | 2446 | 17.0075 |
12:21 ET | 3693 | 16.98 |
12:23 ET | 2000 | 16.9704 |
12:25 ET | 1736 | 16.9692 |
12:27 ET | 4384 | 16.9775 |
12:30 ET | 2851 | 16.9799 |
12:32 ET | 2052 | 16.97 |
12:34 ET | 200 | 16.98 |
12:36 ET | 3800 | 16.98 |
12:38 ET | 2550 | 16.98 |
12:39 ET | 58441 | 16.9628 |
12:41 ET | 6496 | 16.94 |
12:43 ET | 200 | 16.96 |
12:45 ET | 15688 | 16.91 |
12:48 ET | 1719 | 16.9175 |
12:50 ET | 7212 | 16.89 |
12:52 ET | 3500 | 16.91 |
12:54 ET | 6133 | 16.92 |
12:56 ET | 2267 | 16.9006 |
12:57 ET | 10017 | 16.88 |
12:59 ET | 3980 | 16.87 |
01:01 ET | 2390 | 16.875 |
01:03 ET | 72424 | 16.785 |
01:06 ET | 44042 | 16.75 |
01:08 ET | 18060 | 16.75 |
01:10 ET | 4915 | 16.75 |
01:12 ET | 19552 | 16.71 |
01:14 ET | 9064 | 16.74 |
01:15 ET | 6097 | 16.75 |
01:17 ET | 8300 | 16.77 |
01:19 ET | 17140 | 16.72 |
01:21 ET | 21991 | 16.7 |
01:24 ET | 21436 | 16.735 |
01:26 ET | 7104 | 16.72 |
01:28 ET | 5686 | 16.68 |
01:30 ET | 16987 | 16.7 |
01:32 ET | 9938 | 16.7 |
01:33 ET | 14807 | 16.64 |
01:35 ET | 8535 | 16.645 |
01:37 ET | 10749 | 16.67 |
01:39 ET | 5850 | 16.71 |
01:42 ET | 3122 | 16.74 |
01:44 ET | 8354 | 16.71 |
01:46 ET | 4571 | 16.71 |
01:48 ET | 3475 | 16.685 |
01:50 ET | 5022 | 16.68 |
01:51 ET | 1800 | 16.685 |
01:53 ET | 13789 | 16.7 |
01:55 ET | 3511 | 16.68 |
01:57 ET | 2850 | 16.67 |
02:00 ET | 10565 | 16.63 |
02:02 ET | 23882 | 16.6 |
02:04 ET | 27206 | 16.56 |
02:06 ET | 15258 | 16.58 |
02:08 ET | 9764 | 16.61 |
02:09 ET | 3929 | 16.61 |
02:11 ET | 4500 | 16.6 |
02:13 ET | 17184 | 16.59 |
02:15 ET | 3803 | 16.55 |
02:18 ET | 9571 | 16.56 |
02:20 ET | 12607 | 16.58 |
02:22 ET | 8079 | 16.525 |
02:24 ET | 26267 | 16.53 |
02:26 ET | 133524 | 16.48 |
02:27 ET | 6123 | 16.485 |
02:29 ET | 11764 | 16.5066 |
02:31 ET | 10824 | 16.4823 |
02:33 ET | 6754 | 16.475 |
02:36 ET | 9448 | 16.4524 |
02:38 ET | 3938 | 16.46 |
02:40 ET | 21174 | 16.45 |
02:42 ET | 2900 | 16.47 |
02:44 ET | 3564 | 16.46 |
02:45 ET | 4350 | 16.46 |
02:47 ET | 38591 | 16.37 |
02:49 ET | 48002 | 16.3399 |
02:51 ET | 17551 | 16.36 |
02:54 ET | 34077 | 16.455 |
02:56 ET | 8304 | 16.45 |
02:58 ET | 6210 | 16.47 |
03:00 ET | 6267 | 16.42 |
03:02 ET | 4212 | 16.41 |
03:03 ET | 10473 | 16.42 |
03:05 ET | 5496 | 16.46 |
03:07 ET | 8283 | 16.47 |
03:09 ET | 12372 | 16.49 |
03:12 ET | 3220 | 16.4975 |
03:14 ET | 10327 | 16.47 |
03:16 ET | 10835 | 16.455 |
03:18 ET | 13036 | 16.445 |
03:20 ET | 10795 | 16.46 |
03:21 ET | 5184 | 16.47 |
03:23 ET | 10671 | 16.445 |
03:25 ET | 29099 | 16.42 |
03:27 ET | 2684 | 16.43 |
03:30 ET | 25111 | 16.43 |
03:32 ET | 8036 | 16.45 |
03:34 ET | 17961 | 16.395 |
03:36 ET | 15454 | 16.365 |
03:38 ET | 20712 | 16.4 |
03:39 ET | 15120 | 16.46 |
03:41 ET | 20610 | 16.4999 |
03:43 ET | 15463 | 16.492 |
03:45 ET | 15520 | 16.48 |
03:48 ET | 32399 | 16.44 |
03:50 ET | 23640 | 16.41 |
03:52 ET | 28471 | 16.43 |
03:54 ET | 27826 | 16.46 |
03:56 ET | 31950 | 16.48 |
03:57 ET | 84833 | 16.445 |
03:59 ET | 461400 | 16.48 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
TG Therapeutics Inc | 2.5B | 74.7x | --- |
Twist Bioscience Corp | 2.7B | -14.0x | --- |
Vericel Corp | 2.3B | 5,057.5x | --- |
ADMA Biologics Inc | 2.1B | -451.5x | --- |
Arrowhead Pharmaceuticals Inc | 3.1B | -5.8x | --- |
Maravai LifeSciences Holdings Inc | 2.9B | -11.4x | --- |
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.5B |
---|---|
Revenue (TTM) | $289.3M |
Shares Outstanding | 154.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.30 |
EPS | $0.22 |
Book Value | $1.06 |
P/E Ratio | 74.7x |
Price/Sales (TTM) | 8.8 |
Price/Cash Flow (TTM) | 61.6x |
Operating Margin | 16.71% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.